Halozyme Therapeutics (HALO) EBT Margin Growth (5y) (2015 - 2026)
Halozyme Therapeutics (HALO) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,632.00 |
| Dec 31, 2025 | -8,251.00 |
| Sep 30, 2025 | 628.00 |
| Jun 30, 2025 | 1,606.00 |
| Mar 31, 2025 | 7,833.00 |
| Dec 31, 2024 | 12,401.00 |
| Sep 30, 2024 | 11,101.00 |
| Jun 30, 2024 | 8,821.00 |
| Mar 31, 2024 | 4,583.00 |
| Dec 31, 2023 | 4,699.00 |
| Sep 30, 2023 | 15,608.00 |
| Jun 30, 2023 | 10,708.00 |
| Mar 31, 2023 | 12,056.00 |
| Dec 31, 2022 | -2,512.00 |
| Sep 30, 2022 | 3,005.00 |
| Jun 30, 2022 | 11,031.00 |
| Mar 31, 2022 | 17,399.00 |
| Dec 31, 2021 | 12,503.00 |
| Sep 30, 2021 | 15,082.00 |
| Jun 30, 2021 | 14,679.00 |